Innovating Works

MAG

A stranger
LEISHDNAVAX: Development of a DNA vaccine for visceral leishmaniasis MOLOGEN AG participó en un FP7 This project will focus on the preclinical development of a DNA vaccine for human visceral leishmaniasis. The project is based upon the DNA...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.